About UnitedHealth Group Incorporated
https://www.unitedhealthgroup.comUnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.
CEO
Stephen J. Hemsley
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-05-31 | Forward | 2:1 |
| 2003-06-19 | Forward | 2:1 |
ETFs Holding This Stock
VTS.AX
Weight:0.45%
Shares:28.43M
IVV.AX
Weight:0.52%
Shares:11.60M
XUU.TO
Weight:0.46%
Shares:11.60M
Summary
Showing Top 3 of 930
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Raymond James
Strong Buy
UBS
Buy
Jefferies
Buy
Truist Securities
Buy
Deutsche Bank
Buy
Bernstein
Outperform
Grade Summary
Showing Top 6 of 23
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:90.61M
Value:$30.35B
BLACKROCK, INC.
Shares:74.29M
Value:$24.88B
BLACKROCK INC.
Shares:73.43M
Value:$24.6B
Summary
Showing Top 3 of 4,235
About UnitedHealth Group Incorporated
https://www.unitedhealthgroup.comUnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $113.16B ▲ | $16.32B ▲ | $2.35B ▼ | 2.07% ▼ | $2.59 ▼ | $5.33B ▼ |
| Q2-2025 | $111.62B ▲ | $14.86B ▲ | $3.41B ▼ | 3.05% ▼ | $3.76 ▼ | $6.19B ▼ |
| Q1-2025 | $109.58B ▲ | $14.65B ▲ | $6.29B ▲ | 5.74% ▲ | $6.91 ▲ | $10.16B ▲ |
| Q4-2024 | $100.81B ▼ | $13.54B ▼ | $5.54B ▼ | 5.5% ▼ | $5.98 ▼ | $8.84B ▼ |
| Q3-2024 | $100.82B | $14.32B | $6.05B | 6.01% | $6.56 | $9.73B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $30.61B ▼ | $315.27B ▲ | $209.46B ▲ | $95.79B ▲ |
| Q2-2025 | $32.02B ▼ | $308.57B ▼ | $203.79B ▼ | $94.72B ▼ |
| Q1-2025 | $34.29B ▲ | $309.79B ▲ | $204.62B ▲ | $95.04B ▲ |
| Q4-2024 | $29.11B ▼ | $298.28B ▼ | $195.69B ▲ | $92.66B ▼ |
| Q3-2024 | $37.13B | $299.31B | $194.85B | $94.53B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.54B ▼ | $5.95B ▼ | $-4.56B ▼ | $-2.77B ▲ | $-1.36B ▲ | $5.05B ▼ |
| Q2-2025 | $3.57B ▼ | $7.19B ▲ | $-1.44B ▼ | $-7.95B ▼ | $-2.12B ▼ | $6.3B ▲ |
| Q1-2025 | $6.47B ▲ | $5.46B ▲ | $-74M ▲ | $99M ▲ | $5.41B ▲ | $4.56B ▲ |
| Q4-2024 | $5.54B ▼ | $2.37B ▼ | $-1.12B ▲ | $-8.34B ▼ | $-7.09B ▼ | $1.46B ▼ |
| Q3-2024 | $6.05B | $13.95B | $-5.65B | $-2.21B | $6.11B | $12.95B |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Intersegment Eliminations | $-38430.00M ▲ | $-38930.00M ▼ | $-41710.00M ▼ | $-43090.00M ▼ |
 Optumhealth | $25.66Bn ▲ | $25.31Bn ▼ | $25.20Bn ▼ | $25.90Bn ▲ |
 Optuminsight | $4.78Bn ▲ | $4.63Bn ▼ | $4.83Bn ▲ | $4.92Bn ▲ |
 Optumrx | $35.77Bn ▲ | $35.13Bn ▼ | $38.46Bn ▲ | $39.68Bn ▲ |
 Unitedhealthcare | $74.13Bn ▲ | $84.62Bn ▲ | $86.10Bn ▲ | $87.07Bn ▲ |
CEO
Stephen J. Hemsley
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-05-31 | Forward | 2:1 |
| 2003-06-19 | Forward | 2:1 |
ETFs Holding This Stock
VTS.AX
Weight:0.45%
Shares:28.43M
IVV.AX
Weight:0.52%
Shares:11.60M
XUU.TO
Weight:0.46%
Shares:11.60M
Summary
Showing Top 3 of 930
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Raymond James
Strong Buy
UBS
Buy
Jefferies
Buy
Truist Securities
Buy
Deutsche Bank
Buy
Bernstein
Outperform
Grade Summary
Showing Top 6 of 23
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:90.61M
Value:$30.35B
BLACKROCK, INC.
Shares:74.29M
Value:$24.88B
BLACKROCK INC.
Shares:73.43M
Value:$24.6B
Summary
Showing Top 3 of 4,235